Biopharmax India Private Limited, a active foreign private limited company, was established on 15 September 2006 in Pune, Maharashtra, India. Engaging in procurement & construction (epc) within the professional, scientific and technical sector, it holds CIN: U45201PN2006FTC138676. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹0.18 M.
It upholds a compliant status. Employing 65 professional, Its leadership includes Atul Anil Pabalkar (Whole-Time Director), Sandhya Bindumadhav Deshpande (Director), Sarel Chaim Chen Tov (Director). Past directors included Atul Anil Pabalkar, Henry James Meyer, Vikas Madhavrao Tople. It holds ₹4.70 Cr open charges and ₹3.50 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Mantri Alpine, Office No. A-401, 4Th Floor S No 268, Bandal Estate, Bavdhan Bk, Pune, Maharashtra, 411021.
U45201PN2006FTC138676
138676
15 September 2006
₹4.50 Cr
₹0.18 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Biopharmax India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atul Anil Pabalkar | Whole-Time Director | 02 Feb 2022 | Current |
| Sandhya Bindumadhav Deshpande | Director | 27 Jan 2020 | Current |
| Sarel Chaim Chen Tov | Director | 30 Jun 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 02 Feb 2022 | Past |
| Pramod Abcsdd | Director | 31 Mar 2013 | Past |
| Pramod Abcsdd | Director | 27 Jul 2010 | Past |
| Pramod Abcsdd | Director | 05 Oct 2010 | Past |
| Pramod Abcsdd | Additional Director | 24 Dec 2020 | Past |
| Pramod Abcsdd | Director | 06 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biopharmax India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 236.68% increase. The company also saw a substantial improvement in profitability, with a 452.39% increase in profit. The company's net worth Soared by an impressive increase of 106.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Biopharmax India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹47,000,000.00
₹35,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2016 | Others | ₹4.70 Cr | Open |
| 27 Feb 2013 | Icici Bank Limited | ₹3.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Biopharmax India has a workforce of 65 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Biopharmax India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biopharmax India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Biopharmax India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Biopharmax India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
Progress on Atul Anil Pabalkar was appointed as a Whole-time director was appointed as a Whole-time director on 02 Feb 2022 & has been associated with this company since 3 years 10 months . was documented.
The activity A charge with Others of Rs. 4.70 Cr registered on 27 Oct 2016 with Charge ID 100061066 was modified on 27 Dec 2021. was completed.
The activity Sandhya Bindumadhav Deshpande was appointed as a Director was appointed as a Director on 27 Jan 2020 & has been associated with this company since 5 years 10 months . was completed.
The activity A charge registered on 27 Feb 2013 via Charge ID 10410706 with Icici Bank Limited was fully satisfied on 02 Jan 2017. was completed.
The CIN of Biopharmax India Private Limited is U45201PN2006FTC138676.
Biopharmax India Private Limited is headquartered at Mantri Alpine, Office No. A-401, 4Th Floor S No 268, Bandal Estate, Bavdhan Bk, Pune, Maharashtra, 411021.
Biopharmax India Private Limited was incorporated on 15 September 2006.
The current directors of Biopharmax India Private Limited are
The primary industry of Biopharmax India Private Limited is Professional, Scientific And Technical.
Biopharmax India Private Limited is unlisted.
The authorized capital of Biopharmax India Private Limited is ₹4.50 Cr, and the paid-up capital is ₹0.18 M.
The compliance status of Biopharmax India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX